CR. We can all interpret it in different ways and

CR. We can all interpret it in different ways and I have no additional info. I assume it means our data problems and clinical holds will be sorted within the next few months and we can finally hit some targets in the new year. To me, it’s mostly just stating the obvious.

Worth keeping in mind, Dr Recknor has his head down, focused almost entirely on the science. Even if he’s laser-focused on trials or BLA(s) in 2023, a partnership or BO could pop at anytime.

This is a crazy idea… maybe the new President we’re paying a healthy salary to should say something.